Medindia
To Take Care of Your Hypertension? Click Here
Medindia » Cancer News

A 'Star Trek'-Style Medical 'tricorder' to Diagnose Breast Cancer in Minutes

A 'Star Trek'-style medical tricorder , developed Brit scientists can diagnose diseases such as breast cancer in minutes.

by Tanya Thomas on September 4, 2010 at 11:21 AM

Ingenious Brit scientists have developed a 'Star Trek'-style medical "tricorder" capable of diagnosing diseases such as breast cancer in minutes.


The hand-held device analyses a patient's blood, urine or saliva sample to indicate the presence of disease, much like the one used by Dr Leonard "Bones" McCoy in the sci-fi series.

Named the CliniHub, the gadget features a number of "ports" into which samples are placed.

The samples react to chemicals inside the ports, which then change colour to denote diseases in the same way that a pregnancy test turns blue.

CliniHub has been developed by Cambridge Consultants in conjunction with US firm XenBio Fluidics, from California.

Patrick Pordage, from Cambridge Consultants, believes it could be "the future" for diagnosing diseases.

"We are very excited about the possibilities that CliniHub can bring to both patients and GPs across the world," the Scotsman quoted him as saying.

"Quicker analysis of diseases can only lead to better treatment and, in some cases, we hope it could save lives. This technology is a real breakthrough for us.

"The CliniHub could prove to be the future of disease diagnosis and we believe its applications will grow with time," he added.

The netbook-sized CliniHub is expected to cost about 650 pounds.

Its developers predict it will soon be able to detect up to 20 ailments and become commonplace in GP surgeries.

When using the device, doctors insert a blood, urine or saliva sample into one of four USB-sized ports located on the side.

Each port contains a chemical "assay" that has been designed in the US to react in different ways when it detects different antibodies and diseases.

Source: ANI

View Non AMP Site | Back to top ↑